Global biosimilar regulatory harmonization will be needed to reduce development costs and improve patient access, despite ...

Bayer’s consumer health business benefits from a narrow economic moat, largely because of its strong brand power. Consumers continue to pay a premium for Aspirin, Aleve, and other over-the-counter ...

Four Goldman Sachs stock picks make sense for growth and income investors charting a course for the rest of what could be a ...

The appeals court for the Federal Circuit upheld a lower court’s ruling, finding that Regeneron has not sufficiently ...